Did Pfizer buy Arena Pharmaceuticals?

NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.

What is pipeline in pharmaceutical industry?

A drug pipeline is the set of drug candidates that an individual pharmaceutical company or the entire pharmaceutical industry collectively has under discovery or development at any given point in time.

What is Arena Pharmaceuticals known for?

Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas.

How many employees does Arena Pharmaceuticals have?

194 employees
Based in San Diego, CA, Arena Pharmaceuticals is a small health care company with only 194 employees and an annual revenue of $319,000.

What pharmaceutical company is Pfizer buying?

(NYSE: BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.

How many drugs are in the pipeline?

More than 16,000 drugs are expected to be in the R&D pipeline worldwide in 2019, the highest number on record, according to a March 2019 report from Pharma Intelligence.

What is a medical pipeline?

(pīp′līn″) A colloquial term for the active research and development by a biotechnology or pharmaceutical firm of new products, esp. of new drugs.

What happened Arena Pharmaceuticals?

The acquisition was completed by way of a merger in accordance with Delaware law and, as a result of the acquisition, Arena became a wholly-owned subsidiary of Pfizer. In connection with the acquisition, Arena’s shares of common stock will be delisted from the Nasdaq Global Select Market on or about March 11, 2022.

Who bought Arena Pharmaceuticals?

Pfizer
Pfizer has concluded the takeover of the complete outstanding shares, options and restricted stock units of clinical-stage firm Arena Pharmaceuticals for an equity price of nearly $6.7bn or $100 for each share in cash. In December last year, Pfizer entered a definitive agreement to acquire Arena.

Who has the best drug pipeline?

With 213 products in the 2022 R&D pipeline, Novartis leads the ranking, closely followed by another Swiss company, Roche, and by Japanese Takeda. Among the global top 10 companies based on products in the pipeline, five were from the United States.

Who has the best oncology pipeline?

Here we discuss four pharma giants, which possess the industry’s strongest oncology pipeline portfolios.

• AstraZeneca AZN.
• Pfizer PFE.
• Merck.
• Bristol-Myers BMY.
• You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
• Others Not Far Behind.
• Conclusion.
• Large Cap Pharmaceuticals Industry 5YR % Return.

What is pipeline in biotech?

“Pipeline” is the term used to describe all of the projects under development at a company. The pipeline covers work still in discovery and early preclinical phases, through clinical phases 1-3, and finally phase 4, also known as the post-marketing stage.

What is pipeline procedure?

During a flow-diversion/Pipeline™ procedure, a microcatheter is navigated past the aneurysm without having to enter the aneurysm. Then, the flow-diverting device (Pipeline™ Embolization Device) is deployed across the neck of the aneurysm in the parent blood vessel where the aneurysm is present.

Should I buy Arena Pharmaceuticals stock?

The consensus among Wall Street equities research analysts is that investors should “hold” Arena Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ARNA, but not buy additional shares or sell existing shares.

Who are the major stockholders in Moderna?

The top shareholders of Moderna are Robert S. Langer, Stéphane Bancel, Noubar B. Afeyan, Baillie Gifford & Company, and Flagship Pioneering Inc.